Allison Jeynes-Ellis
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 2
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 2
- Rheumatology top 10%
-
- Asthma and respiratory diseases 2
-
- Inhalation and Respiratory Drug Delivery 2
-
- Cancer therapeutics and mechanisms 1
-
- Cancer Mechanisms and Therapy 1
- Lymphoma Diagnosis and Treatment 1
-
- Neuroendocrine Tumor Research Advances 1
- Co-authors
- Charles ChuahPhilipp le CoutreValentín García‐GutiérrezAndreas HochhausIryna DyagilNathalie Bardy‐BouxinJörge E. CortesEric Leip
- Cited by
- HematologyGeneticsRheumatology
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (3 papers)Therapeutic Advances in Respiratory Disease (1 paper)
- Partner nations
- United StatesItalySingapore
In The Last Decade
Allison Jeynes-Ellis
5 papers receiving 389 citations
Hit Papers
Peers
Comparison fields: 5 of 56
- Hematology 282
- Genetics 224
- Rheumatology 124
- Oncology 79
- Physiology 56
Countries citing papers authored by Allison Jeynes-Ellis
This map shows the geographic impact of Allison Jeynes-Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison Jeynes-Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison Jeynes-Ellis more than expected).
Fields of papers citing papers by Allison Jeynes-Ellis
This network shows the impact of papers produced by Allison Jeynes-Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison Jeynes-Ellis. The network helps show where Allison Jeynes-Ellis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Allison Jeynes-Ellis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2022 | 61 | |
| 3 | Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trialbreakdown → | 2017 | 320 |
| 4 | 2017 | 7 | |
| 5 | 2011 | 9 |
About Allison Jeynes-Ellis
Allison Jeynes-Ellis is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 5 papers that have together received 400 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Inhalation and Respiratory Drug Delivery (2 papers), Cancer therapeutics and mechanisms (1 paper), Cancer Mechanisms and Therapy (1 paper), Neuroendocrine Tumor Research Advances (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (282 citations), Genetics (224 citations) and Rheumatology (124 citations). Allison Jeynes-Ellis has collaborated with scholars based in United States, Italy and Singapore. Frequent co-authors include Charles Chuah, Philipp le Coutre, Valentín García‐Gutiérrez, Andreas Hochhaus, Iryna Dyagil, Nathalie Bardy‐Bouxin, Jörge E. Cortes, Eric Leip, Michael J. Mauro and Tim H. Brümmendorf. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Therapeutic Advances in Respiratory Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.